Global Cell Therapy Market Analysis (2019 to 2026) - Key Market Developments and Financials of the Key Players - ResearchAndMarkets.com

The "Global Cell Therapy Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Cell Therapy market is expected to reach $9.76 billion by 2026 growing at a CAGR of 7.2% from 2018 to 2026.

Cell therapy is a technology which relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in the development of regenerative medicines which is a multidisciplinary area aimed at maintenance, improvement, or restoration of a cell, tissue, or organ function using methods mainly related to cell therapy.

Factors such as rising funding from the government as well as private organizations to support cell therapy clinical trials, growing adoption of regenerative medicine and increase in the incidence of diseases such as cancer, cardiac abnormalities are fuelling the market growth. However, the implementation of stringent government regulations regarding the use of cell therapy is anticipated to restrict the growth of the market.

By Therapy Type, Autologous therapies are going to have a significant rate during the forecast period owing to several advantages offered by them such as availability, lower risk of life-threatening complications, low rate of graft failure, low mortality rate, higher affordability and high survival rate of patients. Autologous cell therapy is a branch of regenerative medicine. It involves biologic cell-based therapies to cure various diseases related to oncology, dermatology, and neurology, among others.

The key vendors mentioned are MEDIPOST, AlloCure, Cell Medica, Kolon TissueGene, Inc., Arteriocyte Medical Systems, Forticell Bioscience, Athersys Inc., Stemedica Cell Technologies, Inc., Vericel Corporation, Baxter Healthcare Corporation, JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc., Bone Therapeutics, Cellerant Therapeutics, Celgene Corporation, PHARMICELL Co., Ltd, FibrocellScinence, NuVasive, Inc, and ANTEROGEN.CO., LTD.

Key Questions Answered in this Report:

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Cell Therapy Market, By Therapy Type

5.1 Introduction

5.2 Autologous Therapies

5.3 Allogenic Therapies

6 Global Cell Therapy Market, By Cell Type

6.1 Introduction

6.2 Non-Stem Cell

6.3 Stem Cell

7 Global Cell Therapy Market, By Use & Type

7.1 Introduction

7.2 Research-Use

7.3 Clinical-Use

8 Global Cell Therapy Market, By Therapeutic

8.1 Introduction

8.2 Musculoskeletal Disorders

8.3 Dermatology

8.4 Malignancies

8.5 Autoimmune Disorders

8.6 Other Therapeutics

9 Global Cell Therapy Market, By Technology

9.1 Introduction

9.2 Cell Immortalization Technology

9.3 Genome Editing Technology

9.4 Viral Vector Technology

10 Global Cell Therapy Market, By Product

10.1 Introduction

10.2 Equipment

10.3 Consumables

10.4 Software

10.5 Other Services

11 Global Cell Therapy Market, By Cell Source

11.1 Introduction

11.2 Adipose Tissue

11.3 Umbilical Cord Blood-Derived Cells

11.4 Bone Marrow

12 Global Cell Therapy Market, By Technique

12.1 Introduction

12.2 Fibroblast Cell Therapy

12.3 Cell Vaccine

12.4 Stem Cell Therapy

12.5 Chondrocyte Cell Therapy

12.6 Adoptive Cell Transfer (ACT)

13 Global Cell Therapy Market, By Application

13.1 Introduction

13.2 Cardiovascular Disease (CVD)

13.3 Oncology

13.4 Wound Healing

13.5 Orthopaedic

14 Global Cell Therapy Market, By End User

14.1 Introduction

14.2 Regenerative Medicine Centers

14.3 Academic & Research Institutes

14.4 Hospital & Clinics

15 Global Cell Therapy Market, By Geography

15.1 North America

15.2 Europe

15.3 Asia Pacific

15.4 South America

15.5 Middle East & Africa

16 Strategic Benchmarking

17 Vendors Landscape

17.1 MEDIPOST

17.2 AlloCure

17.3 Cell Medica

17.4 Kolon TissueGene, Inc.

17.5 Arteriocyte Medical Systems

17.6 Forticell Bioscience

17.7 Athersys Inc.

17.8 Stemedica Cell Technologies, Inc.

17.9 Vericel Corporation

17.10 Baxter Healthcare Corporation

17.11 JCR Pharmaceuticals Co., Ltd.

17.12 Osiris Therapeutics, Inc.

17.13 Bone Therapeutics

17.14 Cellerant Therapeutics

17.15 Celgene Corporation

17.16 PHARMICELL Co., Ltd

17.17 FibrocellScinence

17.18 NuVasive, Inc

17.19 ANTEROGEN.CO., LTD

For more information about this report visit https://www.researchandmarkets.com/r/slnpfl

View source version on businesswire.com: https://www.businesswire.com/news/home/20200330005447/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900